Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Keating

Showing results (81-90 of 341) with videos related to

Pageof 35
Sort By:
Cancer|August 14, 2002
In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cellsBarbara Scappini, Francesco Onida, Hagop M Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatmentVarsha Gandhi, William Plunkett, Peter L Bonate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemiaAhmed Awais, Constantine S Tam, Dimitrios Kontoyiannis, et al.
Blood|September 23, 2009
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemiaMarco Herling, Kaushali A Patel, Nicole Weit, et al.
British Journal of Haematology|January 18, 2006
The role of gemtuzumab ozogamicin in acute leukaemia therapyApostolia-Maria Tsimberidou, Francis J Giles, Elihu Estey, et al.
British Journal of Haematology|December 19, 2014
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemiaPhilip A Thompson, Alessandra Ferrajoli, Susan O'Brien, et al.
Leukemia & Lymphoma|September 25, 2015
Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristicsGabriele Todisco, Taghi Manshouri, Srdan Verstovsek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219Cheng-Yu Tsai, Adrian S Ray, Daniel B Tumas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2016
Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia CellsViralkumar Patel, Kumudha Balakrishnan, Elena Bibikova, et al.
Leukemia Research|May 26, 2004
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemiaSrdan Verstovsek, Francis J Giles, Susan O'Brien, et al.
Pageof 35

Showing results (81-90 of 341) with videos related to

Sort By:
Pageof 35
Cancer|August 14, 2002
In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cellsBarbara Scappini, Francesco Onida, Hagop M Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatmentVarsha Gandhi, William Plunkett, Peter L Bonate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemiaAhmed Awais, Constantine S Tam, Dimitrios Kontoyiannis, et al.
Blood|September 23, 2009
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemiaMarco Herling, Kaushali A Patel, Nicole Weit, et al.
British Journal of Haematology|January 18, 2006
The role of gemtuzumab ozogamicin in acute leukaemia therapyApostolia-Maria Tsimberidou, Francis J Giles, Elihu Estey, et al.
British Journal of Haematology|December 19, 2014
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemiaPhilip A Thompson, Alessandra Ferrajoli, Susan O'Brien, et al.
Leukemia & Lymphoma|September 25, 2015
Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristicsGabriele Todisco, Taghi Manshouri, Srdan Verstovsek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219Cheng-Yu Tsai, Adrian S Ray, Daniel B Tumas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2016
Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia CellsViralkumar Patel, Kumudha Balakrishnan, Elena Bibikova, et al.
Leukemia Research|May 26, 2004
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemiaSrdan Verstovsek, Francis J Giles, Susan O'Brien, et al.
Pageof 35